Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

Marim Alwave

6 та иш

Medical Technical College, Al-Farahidi University, Baghdad, Iraq

  1. Novel and potential therapy options for a range of cancer diseases: Using Flavonoid

    Wesam R. Kadhum, Pushpamala Ramaiah, Nahla A. Tayyib +7

    Шарҳ мақолаPhytochemicals and Antioxidant ActivitiesPathology - Research and Practice20230 иқтибос
    ABI

  2. The <scp>microRNAs</scp> ( <scp>miRs</scp> ) overexpressing mesenchymal stem cells ( <scp>MSCs</scp> ) therapy in neurological disorders; hope or hype

    Sulieman Ibraheem Shelash Al‐Hawary, Anas Yahya Ali, Yasser Fakri Mustafa +7

    Шарҳ мақолаNeurogenesis and neuroplasticity mechanismsBiotechnology Progress20230 иқтибос
    ABI

  3. Functionalization of porous silica with graphene oxide and polyethyleneimine, containing zinc copper ferrite nanoparticles for water treatment and antibacterial application

    Ali A. Shati, Mohammad Y. Alfaifi, Serag Eldin I. Elbehairi +7

    МақолаNanomaterials for catalytic reactionsEnvironmental Pollution20240 иқтибос
    ABI

  4. Neuroprotective effects of resveratrol on retinal ganglion cells in glaucoma: Focusing on oxidative stress, cellular, and molecular mechanisms

    Mohammad Yasin Zamanian, Maryam Golmohammadi, Seyed Arash Aghaei Meibodi +7

    ПрепринтGlaucoma and retinal disorders20240 иқтибос
    ABI

  5. Neuroprotective effects of resveratrol on retinal ganglion cells in glaucoma: Focusing on oxidative stress, cellular, and molecular mechanisms

    Maryam Golmohammadi, Seyed Arash Aghaei Meibodi, Sulieman Ibraheem Shelash Al‐Hawary +6

    ПрепринтSirtuins and Resveratrol in Medicine20240 иқтибос
    ABI

  6. Neuroprotective effects of resveratrol on retinal ganglion cells in glaucoma in rodents: A narrative review

    Maryam Golmohammadi, Seyed Arash Aghaei Meibodi, Sulieman Ibraheem Shelash Al‐Hawary +8

    Шарҳ мақолаSirtuins and Resveratrol in MedicineAnimal Models and Experimental Medicine20240 иқтибос
    ABI